(1)
Calabrese, E. The Gofman-Tamplin Cancer Risk Controversy and Its Impact on the Creation of BEIR I and the Acceptance of LNT. Med Lav 2023, 114 (1), e2023007. https://doi.org/10.23749/mdl.v114i1.14006.